Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ATL 001 / Achilles Therap
NCT04785365: Long-Term Follow-Up Study of Patients Receiving ATL001	Terminated	2	1	Europe	Biological: ATL001	Achilles Therapeutics UK Limited	Melanoma, Advanced Non Small Cell Lung Cancer	10/23	10/23
THETIS, NCT03997474 / 2018-003446-16: ATL001 in Patients With Metastatic or Recurrent Melanoma	Terminated	1/2	13	Europe	ATL001, Checkpoint Inhibitor	Achilles Therapeutics UK Limited	Melanoma	09/24	09/24
CHIRON, NCT04032847: ATL001 in Patients with Advanced Unresectable or Metastatic NSCLC	Terminated	1/2	27	Europe, US	ATL001, Pembrolizumab	Achilles Therapeutics UK Limited	Advanced Non Small Cell Lung Cancer	09/24	09/24